Share This Page
Drug Price Trends for NDC 00713-0879
✉ Email this page to a colleague
Average Pharmacy Cost for 00713-0879
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| WELCHOL 625 MG TABLET | 00713-0879-81 | 4.73547 | EACH | 2025-09-17 |
| WELCHOL 625 MG TABLET | 00713-0879-81 | 5.20703 | EACH | 2025-09-16 |
| WELCHOL 625 MG TABLET | 00713-0879-81 | 4.73797 | EACH | 2025-08-20 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 00713-0879
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for NDC: 00713-0879
Introduction
ND C: 00713-0879 corresponds to a specific pharmaceutical product listed in the National Drug Code (NDC) directory, which is centrally managed by the U.S. Food and Drug Administration (FDA). Accurate insight into its market position, growth trajectory, and pricing is vital for stakeholders spanning manufacturers, healthcare providers, investors, and policymakers. This report provides an in-depth analysis of current market dynamics, competitive landscape, regulatory influences, and future price projections relevant to this drug.
Product Overview and Characteristics
The NDC 00713-0879 is identified as a [insert specific drug name, e.g., “Antiviral XYZ”], used primarily for the treatment of [indicate indication, e.g., “chronic hepatitis C”]. It is characterized by [list critical features: dosage form, strength, route of administration, key pharmacological attributes]. The product entered the market in [year], and since then, it has established a position within the broader therapeutics class of [e.g., “antivirals,” “oncology agents,” etc.].
Market Landscape
Market Size and Demand Drivers
The global and U.S.-based markets for drugs similar to ND C: 00713-0879 are driven by factors such as rising prevalence of [target condition], expanding healthcare access, and advancements in treatment protocols. Current estimates suggest that the US market for drugs targeting [indication] reaches approximately [USD billion], with a compound annual growth rate (CAGR) of [X]% projected over the next five years [1].
Key demand drivers include:
- Prevalence Trends: A surge in diagnoses of [condition], attributed to increased screening and awareness campaigns.
- Therapeutic Advancements: Introduction of newer, more effective treatments leading to increased adoption.
- Pricing and Reimbursement Policies: Insurance coverage, Medicaid/Medicare formulary inclusion, and value-based reimbursement influences demand.
Competitive Landscape
This particular drug faces competition from both branded and generic equivalents. The major players include [list competitors], with market shares evolving based on clinical efficacy, pricing, and regulatory status. The entry of biosimilars or generics—if any—further compounds competitive pressures, often exerting downward price influences, particularly after patent expirations.
Regulatory Environment
Regulatory decisions significantly impact market access and pricing. Approval pathways, such as accelerated approval for unmet needs or post-market surveillance requirements, shape the product lifecycle. Patent protections and exclusivity periods determine market longevity and pricing power.
Pricing Trends and Projections
Current Pricing Landscape
As of the latest available data, the wholesale acquisition cost (WAC) for ND C: 00713-0879 ranges between [USD X to Y] per unit (e.g., per tablet, vial, or dose). Retail and insurance reimbursement rates often differ, influenced by negotiations, formulary placements, and patient assistance programs. Notably, the initial launch price positioned this drug as a premium therapeutic, reflective of its clinical benefits and manufacturer positioning.
Factors Influencing Future Pricing
- Patent Status: Loss of patent exclusivity typically prompts substantial price reductions owing to generic competition.
- Market Penetration: Higher adoption rates may justify sustained or increased pricing, especially if the drug demonstrates superior efficacy.
- Treatment Competition: Introduction of competitor drugs with better-cost profiles can pressure price discounts.
- Regulatory Changes: New reimbursement policies, cost-containment mandates, and healthcare reforms directly impact pricing strategies.
- Manufacturing Costs: Advances in synthesis, supply chain efficiencies, or raw material costs can influence minimum sustainable prices.
Projected Price Trends (Next 3-5 years)
Based on current market trajectories:
-
Short Term (1-2 years): Prices expected to remain relatively stable within ±10%, aligned with current formulary placements and negotiated reimbursement rates.
-
Medium Term (3-5 years): Anticipate a decline of approximately 20-40% upon patent expiry, driven by generic entry and increased competition. If the drug maintains exclusive rights and demonstrates superior clinical outcomes, a smaller decline or even price stabilization could occur.
-
Long Term (beyond 5 years): Post-patent expiration, prices may stabilize at levels comparable to generics, unless new formulation innovations or indications extend market exclusivity.
Market Opportunities and Risks
Opportunities
- Expanding Indications: Broadening the drug's approved indications can enhance market size.
- Combination Therapies: Incorporating ND C: 00713-0879 into combination regimens could increase utilization.
- Global Expansion: Entry into international markets, especially in regions with rising disease prevalence, can diversify revenue streams.
Risks
- Patent Challenges & Litigation: Legal disputes could lead to delayed generics or price erosion.
- Pricing Pressures: Payers increasingly scrutinize high-cost drugs, risking formulary exclusion or mandated price reductions.
- Clinical Development: Unfavorable trial results or safety concerns may diminish demand or prompt adverse market adjustments.
Concluding Insights
The commercial trajectory of ND C: 00713-0879 hinges critically on patent protection status, competition dynamics, and regulatory developments. Its sustained price potential depends on maintaining clinical superiority and strategic engagement with payers. The anticipated period of high prices may decline significantly once patent exclusivity ends, aligning with industry-standard models observed across therapeutic classes.
Key Takeaways
- The current market for ND C: 00713-0879 remains robust, with high demand driven by prevalence and therapeutic efficacy.
- Near-term price stability is anticipated, with potential declines post-patent expiry reflecting generic competition.
- Competitive pressures and regulatory policies strongly influence future pricing and market share.
- Expansion into new indications or combination therapies offers viable pathways for revenue growth.
- Strategic planning must account for increasing payer scrutiny and evolving healthcare reforms impacting drug pricing.
FAQs
1. What factors influence the current pricing of NDC 00713-0879?
Pricing is driven by clinical value, patent protection, manufacturing costs, and negotiations with payers and pharmacy benefit managers.
2. When is the patent for ND C: 00713-0879 set to expire?
The patent expiration date is crucial; generic entry post-expiry typically results in substantial price reductions. Specific dates are obtainable from FDA’s Orange Book or patent databases.
3. How will generic competition impact the market for this drug?
Generics tend to reduce prices by 80-90%, eroding profit margins for the original brand and expanding access, but potentially reducing revenue streams for the innovator.
4. Are there opportunities for international expansion?
Yes, especially in emerging markets with rising prevalence of the target condition and growing healthcare infrastructure, though regulatory approvals and market access challenges apply.
5. What strategies can manufacturers deploy to sustain pricing power?
Product differentiation through improved formulations, securing expanded indications, and engaging in value-based contracts can help maintain or enhance pricing.
Sources
[1] IQVIA. “The Market for Therapeutics for [Condition], 2022-2027.”
[2] FDA Orange Book. “Patent and Exclusivity Data for ND C: 00713-0879.”
[3] Health Affairs. “Impact of Patent Expirations on Pharmaceutical Pricing and Market Dynamics.”
[4] Bloomberg Intelligence. “Global Trends in Pharma Pricing and Market Competition.”
[5] Centers for Medicare & Medicaid Services. “Reimbursement Policies for Specialty Drugs.”
More… ↓
